ANKRD27
Basic information
Region (hg38): 19:32597006-32676597
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANKRD27 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 62 | 65 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 62 | 4 | 0 |
Variants in ANKRD27
This is a list of pathogenic ClinVar variants found in the ANKRD27 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-32598240-G-C | not specified | Uncertain significance (Dec 18, 2023) | ||
19-32598303-T-A | not specified | Uncertain significance (Sep 14, 2022) | ||
19-32598327-C-T | not specified | Likely benign (Aug 08, 2022) | ||
19-32599733-G-C | not specified | Uncertain significance (Jun 06, 2022) | ||
19-32599768-G-A | not specified | Uncertain significance (Jan 18, 2023) | ||
19-32600050-C-G | not specified | Uncertain significance (Jun 13, 2022) | ||
19-32604277-C-T | not specified | Uncertain significance (Jul 14, 2023) | ||
19-32604294-C-T | not specified | Uncertain significance (May 08, 2023) | ||
19-32604340-C-T | not specified | Uncertain significance (Aug 01, 2022) | ||
19-32604343-C-T | not specified | Uncertain significance (May 26, 2022) | ||
19-32605921-G-A | not specified | Uncertain significance (Apr 30, 2024) | ||
19-32605932-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
19-32605947-T-G | not specified | Uncertain significance (Jan 07, 2022) | ||
19-32607703-T-C | not specified | Uncertain significance (Apr 04, 2024) | ||
19-32607727-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
19-32607738-G-A | not specified | Likely benign (Nov 13, 2023) | ||
19-32607741-C-G | not specified | Uncertain significance (Nov 09, 2021) | ||
19-32607747-T-C | not specified | Uncertain significance (Apr 07, 2022) | ||
19-32607753-G-A | not specified | Uncertain significance (Jan 19, 2024) | ||
19-32607754-C-A | not specified | Uncertain significance (Jan 04, 2024) | ||
19-32607768-G-A | not specified | Uncertain significance (May 26, 2023) | ||
19-32607786-C-T | Likely benign (Aug 01, 2022) | |||
19-32607793-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
19-32607832-T-C | not specified | Uncertain significance (Jun 27, 2022) | ||
19-32615695-G-A | not specified | Uncertain significance (Jan 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ANKRD27 | protein_coding | protein_coding | ENST00000306065 | 28 | 79591 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.86e-31 | 0.000788 | 125555 | 1 | 192 | 125748 | 0.000768 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.271 | 602 | 584 | 1.03 | 0.0000340 | 6847 |
Missense in Polyphen | 60 | 60.327 | 0.99457 | 628 | ||
Synonymous | -0.588 | 257 | 245 | 1.05 | 0.0000166 | 2015 |
Loss of Function | 0.885 | 51 | 58.3 | 0.875 | 0.00000288 | 699 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00139 | 0.00132 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000603 | 0.000598 |
Finnish | 0.000835 | 0.000832 |
European (Non-Finnish) | 0.000748 | 0.000721 |
Middle Eastern | 0.000603 | 0.000598 |
South Asian | 0.00137 | 0.00131 |
Other | 0.000852 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: May be a guanine exchange factor (GEF) for Rab21, Rab32 and Rab38 and regulate endosome dynamics (PubMed:16525121, PubMed:18477474). May regulate the participation of VAMP7 in membrane fusion events; in vitro inhibits VAMP7-mediated SNARE complex formation by trapping VAMP7 in a closed, fusogenically inactive conformation (PubMed:23104059). Involved in peripheral melanosomal distribution of TYRP1 in melanocytes; the function, which probably is implicating vesicle-trafficking, includes cooperation with Rab32, Rab38 and VAMP7 (By similarity). Involved in the regulation of neurite growth; the function seems to require its GEF activity, probably towards Rab21, and VAMP7 but not Rab32/38 (By similarity). Proposed to be involved in Golgi sorting of VAMP7 and transport of VAMP7 vesicles to the cell surface; the function seems to implicate kinesin heavy chain isoform 5 proteins, GOLGA4, RAB21 and MACF1 (PubMed:22705394). Required for the colocalization of VAMP7 and Rab21, probably on TGN sites (PubMed:19745841). Involved in GLUT1 endosome-to-plasma membrane trafficking; the function is dependent of association with VPS29 (PubMed:24856514). Regulates the proper trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes (By similarity). {ECO:0000250|UniProtKB:Q3UMR0, ECO:0000269|PubMed:23104059, ECO:0000269|PubMed:24856514, ECO:0000305|PubMed:16525121, ECO:0000305|PubMed:18477474, ECO:0000305|PubMed:22705394}.;
- Pathway
- Vesicle-mediated transport;Membrane Trafficking;Rab regulation of trafficking;RAB GEFs exchange GTP for GDP on RABs
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.956
- rvis_EVS
- -1.56
- rvis_percentile_EVS
- 3.21
Haploinsufficiency Scores
- pHI
- 0.601
- hipred
- N
- hipred_score
- 0.289
- ghis
- 0.590
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.347
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ankrd27
- Phenotype
- skeleton phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein transport;negative regulation of SNARE complex assembly;endosome to melanosome transport;positive regulation of GTPase activity;early endosome to late endosome transport;neuron projection morphogenesis;positive regulation of dendrite morphogenesis;retrograde transport, endosome to plasma membrane
- Cellular component
- lysosome;early endosome;late endosome;cytosol;plasma membrane;membrane;transport vesicle;cytoplasmic vesicle membrane;melanosome;neuron projection;tubular endosome
- Molecular function
- SNARE binding;guanyl-nucleotide exchange factor activity;GTPase activator activity;protein binding;Rab guanyl-nucleotide exchange factor activity;Rab GTPase binding